HITK Financial Facts
DILUTED INCOME PER SHARE: 0.59Contract research (income): 0
See Full Income Statement
Retained earnings: 182.39M
Long-term debt: 0
See Full Balance Sheet
Hi Tech Pharmacal Co. Inc. (HITK) Earnings
|
Expand Research on HITK
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
12/5/11 | Q212 | $1.04 | $0.77 | +$0.27 | $56.88M | $51.4M | N/A | Details | |||
3/8/12 | Q411 | $0.79 | $0.87 | -$0.08 | $55.63M | $55.73M | N/A | Details | |||
9/7/11 | Q112 | $1.05 | $0.84 | +$0.21 | $56.21M | $54.07M | N/A | Details | |||
7/7/11 | Q411 | $1.08 | $0.71 | +$0.37 | $57.2M | $49.33M | N/A | Details | |||
12/9/10 | Q210 | $0.76 | $0.56 | +$0.20 | N/A | N/A | N/A | Details | |||
3/10/11 | Q311 | $0.79 | $0.63 | +$0.16 | $50M | $45.33M | N/A | Details | |||
7/10/12 | Q412 | $0.73 | $0.78 | -$0.05 | $61.3M | $57.94M | N/A | Details | |||
9/5/12 | Q113 | $0.44 | $0.68 | -$0.24 | $52M | $57.6M | N/A | Details |